Literature DB >> 9772012

Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease.

M C Morris1, L A Beckett, P A Scherr, L E Hebert, D A Bennett, T S Field, D A Evans.   

Abstract

Oxidative stress may play a role in neurologic disease. The present study examined the relation between use of vitamin E and vitamin C and incident Alzheimer disease in a prospective study of 633 persons 65 years and older. A stratified random sample was selected from a disease-free population. At baseline, all vitamin supplements taken in the previous 2 weeks were identified by direct inspection. After an average follow-up period of 4.3 years, 91 of the sample participants with vitamin information met accepted criteria for the clinical diagnosis of Alzheimer disease. None of the 27 vitamin E supplement users had Alzheimer disease compared with 3.9 predicted based on the crude observed incidence among nonusers (p = 0.04) and 2.5 predicted based on age, sex, years of education, and length of follow-up interval (p = 0.23). None of the 23 vitamin C supplement users had Alzheimer disease compared with 3.3 predicted based on the crude observed incidence among nonusers (p = 0.10) and 3.2 predicted adjusted for age, sex, education, and follow-up interval (p = 0.04). There was no relation between Alzheimer disease and use of multivitamins. These data suggest that use of the higher-dose vitamin E and vitamin C supplements may lower the risk of Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9772012     DOI: 10.1097/00002093-199809000-00001

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  61 in total

Review 1.  What we need to know about age related memory loss.

Authors:  Gary W Small
Journal:  BMJ       Date:  2002-06-22

Review 2.  Diet and Alzheimer's disease: what the evidence shows.

Authors:  Martha Clare Morris
Journal:  MedGenMed       Date:  2004-01-15

Review 3.  Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders.

Authors:  Karen Berman; Henry Brodaty
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

Authors:  Magali Dumont; Michael T Lin; M Flint Beal
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Comparisons of plasma/serum micronutrients between Okinawan and Oregonian elders: a pilot study.

Authors:  Hiroko H Dodge; Yuriko Katsumata; Hidemi Todoriki; Shoutoku Yasura; D Craig Willcox; Gene L Bowman; Bradley Willcox; Scott Leonard; Aaron Clemons; Barry S Oken; Jeffrey A Kaye; Maret G Traber
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-07-19       Impact factor: 6.053

6.  Effects of an antioxidant beverage on biomarkers of oxidative stress in Alzheimer's patients.

Authors:  Jose M Rubio-Perez; Maria D Albaladejo; Pilar Zafrilla; Maria L Vidal-Guevara; Juana M Morillas-Ruiz
Journal:  Eur J Nutr       Date:  2015-08-23       Impact factor: 5.614

7.  Pharmacotherapy in the treatment of Alzheimer's disease: an update.

Authors:  Brian E Leonard
Journal:  World Psychiatry       Date:  2004-06       Impact factor: 49.548

8.  Is vitamin E toxic to neuron cells?

Authors:  Sue Mian Then; Musalmah Mazlan; Gapor Mat Top; Wan Zurinah Wan Ngah
Journal:  Cell Mol Neurobiol       Date:  2009-01-27       Impact factor: 5.046

Review 9.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

10.  Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics.

Authors:  S Melov; S R Doctrow; J A Schneider; J Haberson; M Patel; P E Coskun; K Huffman; D C Wallace; B Malfroy
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.